These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-3672603
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
12300 Grant Street, Thornton, CO
|
|
80241
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
|
o
|
|
Accelerated filer
|
|
o
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
|
||
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
ASSETS
|
|
|
|
|
||||
|
Current Assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
6,946,368
|
|
|
$
|
12,621,477
|
|
|
Trade receivables
|
|
169,141
|
|
|
100,164
|
|
||
|
Related party receivables and deposits
|
|
508,108
|
|
|
596,339
|
|
||
|
Inventories
|
|
2,167,264
|
|
|
2,159,553
|
|
||
|
Prepaid expenses and other current assets
|
|
526,392
|
|
|
235,305
|
|
||
|
Total current assets
|
|
10,317,273
|
|
|
15,712,838
|
|
||
|
Property, Plant and Equipment:
|
|
39,264,868
|
|
|
39,979,013
|
|
||
|
Less accumulated depreciation and amortization
|
|
(13,374,218
|
)
|
|
(12,725,298
|
)
|
||
|
|
|
25,890,650
|
|
|
27,253,715
|
|
||
|
Other Assets:
|
|
|
|
|
||||
|
Patents, net of amortization of $56,062 and $48,150, respectively
|
|
579,131
|
|
|
500,879
|
|
||
|
Other non-current assets
|
|
55,625
|
|
|
56,563
|
|
||
|
|
|
634,756
|
|
|
557,442
|
|
||
|
Total Assets
|
|
$
|
36,842,679
|
|
|
$
|
43,523,995
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Current Liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
671,940
|
|
|
$
|
855,373
|
|
|
Accrued expenses
|
|
1,585,604
|
|
|
1,788,635
|
|
||
|
Current portion of long-term debt
|
|
269,331
|
|
|
264,935
|
|
||
|
Total current liabilities
|
|
2,526,875
|
|
|
2,908,943
|
|
||
|
Long-Term Debt
|
|
6,281,131
|
|
|
6,350,135
|
|
||
|
Accrued Warranty Liability
|
|
41,403
|
|
|
38,187
|
|
||
|
Commitments and Contingencies (Notes 4 & 11)
|
|
|
|
|
||||
|
Stockholders’ Equity:
|
|
|
|
|
||||
|
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, no shares outstanding
|
|
—
|
|
|
—
|
|
||
|
Common stock, $0.0001 par value, 125,000,000 shares authorized; 51,523,758 and 51,143,906 shares issued and outstanding, respectively
|
|
5,152
|
|
|
5,114
|
|
||
|
Additional paid in capital
|
|
246,197,803
|
|
|
245,996,950
|
|
||
|
Deficit accumulated during the development stage
|
|
(218,209,685
|
)
|
|
(211,775,334
|
)
|
||
|
Total stockholders’ equity
|
|
27,993,270
|
|
|
34,226,730
|
|
||
|
Total Liabilities and Stockholders’ Equity
|
|
$
|
36,842,679
|
|
|
$
|
43,523,995
|
|
|
|
|
For the Three Months Ended
|
|
For the Period from Inception (October 18, 2005) Through March 31, 2013 *
|
||||||||
|
|
|
March 31,
|
|
|||||||||
|
|
|
2013
|
|
2012
|
|
|||||||
|
Revenues
|
|
|
|
|
|
|
||||||
|
Products
|
|
$
|
175,685
|
|
|
$
|
10,234
|
|
|
$
|
2,103,948
|
|
|
Government contracts
|
|
59,252
|
|
|
431,332
|
|
|
9,726,301
|
|
|||
|
Total Revenues
|
|
234,937
|
|
|
441,566
|
|
|
11,830,249
|
|
|||
|
Costs and Expenses
|
|
|
|
|
|
|
||||||
|
Research and development
|
|
5,320,229
|
|
|
4,390,325
|
|
|
105,734,465
|
|
|||
|
Selling, general and administrative
|
|
1,242,591
|
|
|
1,494,111
|
|
|
42,073,009
|
|
|||
|
Impairment loss
|
|
—
|
|
|
—
|
|
|
83,171,090
|
|
|||
|
Total Costs and Expenses
|
|
6,562,820
|
|
|
5,884,436
|
|
|
230,978,564
|
|
|||
|
Loss from Operations
|
|
(6,327,883
|
)
|
|
(5,442,870
|
)
|
|
(219,148,315
|
)
|
|||
|
Other Income/(Expense), net
|
|
(106,468
|
)
|
|
(67,636
|
)
|
|
938,630
|
|
|||
|
Net Loss
|
|
$
|
(6,434,351
|
)
|
|
$
|
(5,510,506
|
)
|
|
$
|
(218,209,685
|
)
|
|
Other Comprehensive Income (Loss)
|
|
|
|
|
|
|
||||||
|
Unrealized gain (loss) on investments
|
|
—
|
|
|
(966
|
)
|
|
—
|
|
|||
|
Comprehensive Loss
|
|
$
|
(6,434,351
|
)
|
|
$
|
(5,511,472
|
)
|
|
$
|
(218,209,685
|
)
|
|
|
|
|
|
|
|
|
||||||
|
Net Loss Per Share
(Basic and diluted)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.14
|
)
|
|
|
||
|
Weighted Average Common Shares Outstanding
(Basic and diluted)
|
|
51,333,822
|
|
|
40,547,280
|
|
|
|
||||
|
|
|
|
|
For the Period
from Inception
(October 18, 2005)
through
March 31,
|
||||||||
|
|
|
For the Three Months Ended
|
|
|||||||||
|
|
|
March 31,
|
|
|||||||||
|
|
|
2013
|
|
2012
|
|
2013
|
||||||
|
Operating Activities:
|
|
|
|
|
|
|
||||||
|
Net loss
|
|
$
|
(6,434,351
|
)
|
|
$
|
(5,510,506
|
)
|
|
$
|
(218,209,685
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
1,542,479
|
|
|
1,444,011
|
|
|
26,055,626
|
|
|||
|
Stock based compensation
|
|
174,891
|
|
|
350,342
|
|
|
12,986,583
|
|
|||
|
Common stock issued for services
|
|
26,000
|
|
|
—
|
|
|
84,950
|
|
|||
|
Realized loss on forward contracts
|
|
—
|
|
|
—
|
|
|
1,430,766
|
|
|||
|
Foreign currency transaction loss (gain)
|
|
—
|
|
|
5,365
|
|
|
(590,433
|
)
|
|||
|
Amortization of financing costs and discounts
|
|
—
|
|
|
—
|
|
|
998,565
|
|
|||
|
Impairment loss
|
|
—
|
|
|
—
|
|
|
83,171,090
|
|
|||
|
Contract cancellation loss
|
|
—
|
|
|
—
|
|
|
1,167,586
|
|
|||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
||||||
|
Accounts receivable
|
|
(68,977
|
)
|
|
(6,637
|
)
|
|
(169,141
|
)
|
|||
|
Related party receivables and deposits
|
|
88,231
|
|
|
—
|
|
|
(508,108
|
)
|
|||
|
Inventories
|
|
(7,711
|
)
|
|
148,095
|
|
|
(2,167,264
|
)
|
|||
|
Prepaid expenses and other current assets
|
|
(291,087
|
)
|
|
(315,287
|
)
|
|
(526,392
|
)
|
|||
|
Accounts payable
|
|
(183,433
|
)
|
|
(92,792
|
)
|
|
671,939
|
|
|||
|
Accrued expenses
|
|
20,513
|
|
|
(42,098
|
)
|
|
858,111
|
|
|||
|
Deferred revenue
|
|
—
|
|
|
12,190
|
|
|
—
|
|
|||
|
Warranty reserve
|
|
3,216
|
|
|
—
|
|
|
41,403
|
|
|||
|
Net cash used in operating activities
|
|
(5,130,229
|
)
|
|
(4,007,317
|
)
|
|
(94,704,404
|
)
|
|||
|
Investing Activities:
|
|
|
|
|
|
|
||||||
|
Purchases of available-for-sale securities
|
|
—
|
|
|
(638,572
|
)
|
|
(907,118,828
|
)
|
|||
|
Maturities and sales of available-for-sale securities
|
|
—
|
|
|
6,884,867
|
|
|
907,118,828
|
|
|||
|
Purchase of property, plant and equipment
|
|
(394,108
|
)
|
|
(2,690,956
|
)
|
|
(135,216,111
|
)
|
|||
|
Restricted cash for manufacturing equipment
|
|
—
|
|
|
958,686
|
|
|
—
|
|
|||
|
Patent activity costs
|
|
(86,164
|
)
|
|
(25,680
|
)
|
|
(610,235
|
)
|
|||
|
Net cash provided by (used in) investing activities
|
|
(480,272
|
)
|
|
4,488,345
|
|
|
(135,826,346
|
)
|
|||
|
Financing Activities:
|
|
|
|
|
|
|
||||||
|
Proceeds from bridge loan financing
|
|
—
|
|
|
—
|
|
|
1,600,000
|
|
|||
|
Repayment of bridge loan financing
|
|
—
|
|
|
—
|
|
|
(1,600,000
|
)
|
|||
|
Payment of debt financing costs
|
|
—
|
|
|
—
|
|
|
(273,565
|
)
|
|||
|
Payment of equity offering costs
|
|
—
|
|
|
—
|
|
|
(10,302,040
|
)
|
|||
|
Proceeds from debt
|
|
—
|
|
|
—
|
|
|
7,700,000
|
|
|||
|
Repayment of debt
|
|
(64,608
|
)
|
|
(460,493
|
)
|
|
(2,249,538
|
)
|
|||
|
Proceeds from shareholder under Section 16(b)
|
|
—
|
|
|
—
|
|
|
148,109
|
|
|||
|
Proceeds from issuance of stock and warrants
|
|
—
|
|
|
1,234,391
|
|
|
242,502,280
|
|
|||
|
Redemption of Class A warrants
|
|
—
|
|
|
—
|
|
|
(48,128
|
)
|
|||
|
Net cash provided by (used in) financing activities
|
|
(64,608
|
)
|
|
773,898
|
|
|
237,477,118
|
|
|||
|
Net change in cash and cash equivalents
|
|
(5,675,109
|
)
|
|
1,254,926
|
|
|
6,946,368
|
|
|||
|
Cash and cash equivalents at beginning of period
|
|
12,621,477
|
|
|
11,298,885
|
|
|
—
|
|
|||
|
Cash and cash equivalents at end of period
|
|
$
|
6,946,368
|
|
|
$
|
12,553,811
|
|
|
$
|
6,946,368
|
|
|
Non-Cash Transactions:
|
|
|
|
|
|
|
||||||
|
ITN initial contribution of assets for equity
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
31,200
|
|
|
Note with ITN and related capital expenditures
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,100,000
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2013
|
|
2012
|
||||
|
Building
|
|
$
|
5,820,509
|
|
|
$
|
5,820,735
|
|
|
Furniture, fixtures, computer hardware and computer software
|
|
435,267
|
|
|
426,517
|
|
||
|
Manufacturing machinery and equipment
|
|
33,009,092
|
|
|
32,847,052
|
|
||
|
Leasehold improvements
|
|
—
|
|
|
884,709
|
|
||
|
Net depreciable property, plant and equipment
|
|
39,264,868
|
|
|
39,979,013
|
|
||
|
Less: Accumulated depreciation and amortization
|
|
(13,374,218
|
)
|
|
(12,725,298
|
)
|
||
|
Net property, plant and equipment
|
|
$
|
25,890,650
|
|
|
$
|
27,253,715
|
|
|
•
|
Level 1 - Quoted prices in active markets for identical assets or liabilities.
|
|
•
|
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|
|
•
|
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
|
|
|
For the three months ended March 31,
|
||||||
|
|
|
2013
|
|
2012
|
||||
|
Interest cost incurred
|
|
$
|
109,732
|
|
|
$
|
113,847
|
|
|
Interest cost capitalized
|
|
—
|
|
|
(46,331
|
)
|
||
|
Interest expense, net
|
|
$
|
109,732
|
|
|
$
|
67,516
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2013
|
|
2012
|
||||
|
Raw materials
|
|
$
|
1,751,613
|
|
|
$
|
1,794,224
|
|
|
Work in process
|
|
156,124
|
|
|
172,227
|
|
||
|
Finished goods
|
|
259,527
|
|
|
193,102
|
|
||
|
Total
|
|
$
|
2,167,264
|
|
|
$
|
2,159,553
|
|
|
|
|
||
|
2013
|
$
|
200,327
|
|
|
2014
|
282,960
|
|
|
|
2015
|
302,210
|
|
|
|
2016
|
322,771
|
|
|
|
2017
|
344,730
|
|
|
|
Thereafter
|
5,097,464
|
|
|
|
|
$
|
6,550,462
|
|
|
|
|
For the three months ended March 31,
|
||||||
|
|
|
2013
|
|
2012
|
||||
|
Share-based compensation cost included in:
|
|
|
|
|
||||
|
Research and development
|
|
$
|
66,256
|
|
|
$
|
102,165
|
|
|
Selling, general and administrative
|
|
108,635
|
|
|
248,177
|
|
||
|
Total share-based compensation cost
|
|
$
|
174,891
|
|
|
$
|
350,342
|
|
|
|
|
For the three months ended March 31,
|
||||||
|
|
|
2013
|
|
2012
|
||||
|
Type of Award:
|
|
|
|
|
||||
|
Stock Options
|
|
$
|
104,950
|
|
|
$
|
190,279
|
|
|
Restricted Stock Units and Awards
|
|
69,941
|
|
|
160,063
|
|
||
|
Total share-based compensation cost
|
|
$
|
174,891
|
|
|
$
|
350,342
|
|
|
|
|
For the three months ended March 31,
|
||
|
|
|
2013
|
|
2012
|
|
Expected volatility
|
|
97%
|
|
103%
|
|
Risk free interest rate
|
|
1%
|
|
1%
|
|
Expected dividends
|
|
—
|
|
—
|
|
Expected life (in years)
|
|
5.2
|
|
5.2
|
|
•
|
we can generate customer acceptance of and demand for our products;
|
|
•
|
we successfully ramp up commercial production on the equipment installed;
|
|
•
|
our products are successfully and timely certified for use in our target markets;
|
|
•
|
we successfully operate production tools to achieve the efficiencies, throughput and yield necessary to reach our cost targets;
|
|
•
|
the products we design are saleable at a price sufficient to generate profits;
|
|
•
|
our strategic alliance with TFG Radiant results in the design, manufacture and sale of sufficient products to achieve profitability;
|
|
•
|
we raise sufficient capital to enable us to reach a level of sales sufficient to achieve profitability, on terms favorable to us;
|
|
•
|
we are able to be successful in designing, manufacturing, marketing, distributing and selling our newly introduced line of consumer oriented products;
|
|
•
|
we effectively manage the planned ramp up of our operations;
|
|
•
|
we are able to maintain the listing of our common stock on the NASDAQ Global Market or Capital Market;
|
|
•
|
we are able to achieve projected operational performance and cost metrics;
|
|
•
|
we successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators and distributors, who deal directly with end users in our target markets;
|
|
•
|
we are able to enter into commercially viable licensing, joint venture, or other commercial arrangements; and
|
|
•
|
raw materials are available to us on acceptable terms and in sufficient quantities.
|
|
|
|
Decrease (increase)
to Net Loss
For the Three
Months Ended
March 31, 2013 Compared to the Three Months Ended
March 31, 2012
|
||
|
Revenues
|
|
|
||
|
Products
|
|
$
|
165,000
|
|
|
Government Contracts
|
|
(372,000
|
)
|
|
|
Research and development costs
|
|
|
||
|
Manufacturing research and development
|
|
(1,257,000
|
)
|
|
|
Government research and development
|
|
291,000
|
|
|
|
Non-cash stock based compensation
|
|
36,000
|
|
|
|
Selling, general and administrative expenses
|
|
|
||
|
Corporate selling, general and administrative
|
|
112,000
|
|
|
|
Non-cash stock based compensation
|
|
140,000
|
|
|
|
Other Income / (Expense), net
|
|
(39,000
|
)
|
|
|
Increase to Net Loss
|
|
$
|
(924,000
|
)
|
|
|
|
|
|
Payments Due by Year (in thousands)
|
||||||||||||||||
|
Contractual Obligations
|
|
Total
|
|
Less Than 1
Year
|
|
1-3 Years
|
|
3-5 Years
|
|
More Than 5
Years
|
||||||||||
|
Long-term debt obligations
|
|
$
|
10,289
|
|
|
$
|
694
|
|
|
$
|
2,081
|
|
|
$
|
2,081
|
|
|
$
|
5,433
|
|
|
Operating lease obligations
|
|
52
|
|
|
52
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Purchase obligations
|
|
1,232
|
|
|
1,232
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
|
$
|
11,573
|
|
|
$
|
1,978
|
|
|
$
|
2,081
|
|
|
$
|
2,081
|
|
|
$
|
5,433
|
|
|
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
By:
|
/
S
/ G
ARY
G
ATCHELL
|
|
|
|
Gary Gatchell
Chief Financial Officer
(Principal Financial Officer and Authorized Signatory)
|
|
Exhibit
No.
|
|
Description
|
|
31.1*
|
|
Chief Executive Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
31.2*
|
|
Chief Financial Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
32.1*
|
|
Chief Executive Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
32.2*
|
|
Chief Financial Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
101.INS**
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB**
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Filed herewith.
|
|
|
|
|
**
|
XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Exchange Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|